---
title: "NanFang Precision: Plans to adjust the A-share issuance scheme to specific targets, with a total fundraising amount not exceeding 202 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240593953.md"
description: "NanFang Precision announced plans to adjust the issuance of A-shares to specific targets, with a total fundraising amount not exceeding 202 million yuan and the number of shares issued not exceeding 30% of the company's total share capital. The raised funds will be used for the construction projects of precision braking, transmission components, and industrial bearing production lines. This plan needs to be implemented after being reviewed by the Shenzhen Stock Exchange and approved for registration by the China Securities Regulatory Commission"
datetime: "2025-05-16T12:58:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240593953.md)
  - [en](https://longbridge.com/en/news/240593953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240593953.md)
generator: "portal-rs"
---

# NanFang Precision: Plans to adjust the A-share issuance scheme to specific targets, with a total fundraising amount not exceeding 202 million yuan

NanFang Precision announced that in order to promote the smooth progress of the issuance of A-shares to specific targets, and in conjunction with the company's actual situation, the company plans to adjust the amount of funds raised in this issuance. After the adjustment, the number of shares issued will not exceed 30% of the company's total share capital before the issuance, and the total amount of funds raised will not exceed 202 million yuan. The raised funds will be used for the construction projects of precision braking and transmission component production lines and precision industrial bearing production lines. This issuance is subject to approval by the Shenzhen Stock Exchange and must be registered with the China Securities Regulatory Commission before implementation

### Related Stocks

- [002553.CN](https://longbridge.com/en/quote/002553.CN.md)

## Related News & Research

- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [14:41 ETNine Corboy & Demetrio Attorneys selected to 2027 The Best Lawyers in America®](https://longbridge.com/en/news/296644470.md)
- [Cell C publishes pro forma financials after Comm Equipment Company merger](https://longbridge.com/en/news/296585930.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**